Dermatomyositis and Polymyositis Registry

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

By creating a registry, physicians will have the opportunity to understand the clinical outcomes of Myositis patients treated with Acthar. Despite the availability of clinical exams, muscle biopsies, and other testing, it is surmised that there may be a more important classification of myositis that physicians are not diagnosing which could possibly lead to improper treatment due to inaccurate diagnosis. There may be several types of immune and inflammatory myositis (IIM) that do not fit well into the typical sub classifications of myositis.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Phoenix Neurological Associates, LTD
• Treatments: Adrenocorticotropic Hormone

Criteria

Inclusion Criteria:

1. Age 18-85

2. Male or Female

3. Clinical or pathologic diagnosis of polymyositis or dermatomyositis

4. Capable of providing informed consent and complying with treatment regimen

Exclusion Criteria:

1. History of scleroderma, osteoporosis, systemic fungal infections, ocular herpes simplex

2. Recent surgery, history of or the presence of a peptic ulcer, congestive heart failure, uncontrolled hypertension, or sensitivity to proteins of porcine origin

3. Any other co-morbid condition which would make completion of the trial unlikely

4. If female, pregnant or breast-feeding; or, if of childbearing age, an unwillingness to use appropriate birth control